Discover more from Dr. Panda's Newsletter
Oh no! Vaccine Sales Are Falling!
Also another side effect — new study shows mRNAs might make you go blind!
The (Somewhat) Good News
Looks like vaccine uptake is coming to a crawl. Pfizer reported their first quarter results on Tuesday. Vaccine sales are down 77% and revenues declined by 29% in the first quarter of 2023 compared to the same period in 2022. Their stock is also down 25% year-to-date.
The company attributed the decline to a number of factors, including:
Lower demand for COVID-19 vaccines: Pfizer's COVID-19 vaccine generated $3 billion in revenue in the first quarter of 2022, but ‘only’ $1 billion in revenue in the first quarter of 2023. Pfizer blamed the decline was due to a number of factors, including the fact that many countries have already vaccinated their populations and the fact that the Omicron variant of COVID-19 is less severe than previous variants.
Lower demand for COVID-19 antiviral pill Paxlovid: Pfizer's COVID-19 antiviral pill, Paxlovid, generated $400 million in revenue in the first quarter of 2022, but ‘only’ $200 million in revenue in the first quarter of 2023. Again Pfizer blamed the fact that Paxlovid is only approved for high-risk patients and the fact that it is still in short supply.
Increased competition: Pfizer said they face increased competition from other pharmaceutical companies that are developing their own COVID-19 vaccines and antiviral pills. This competition is likely to continue to put pressure on Pfizer's revenues in the future.
Despite the decline in vaccines, Pfizer still reported a profit of $5.5 billion in the first quarter of 2023 “helped by sales of certain rare-disease and cancer drugs.”
In 2021, the world was vaccinating at a rate of 40-45 million doses per day. This rate has since slowed to a few hundred thousand doses per day.
Dr. Panda's Newsletter is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
The Bad News
Pfizer wants to combine its COVID-19 vaccine with its flu and RSV vaccines in a single shot. The company is currently conducting clinical trials of the combination vaccine, and it hopes to have it available for the 2023-2024 flu season.
Pfizer hopes to drive vaccine uptake with this new combo vax.
Pfizer is not the only company working on a combination vaccine. Moderna and Novavax are also developing combination vaccines against COVID-19 and the flu.
Another Day Another Study
A new large scale study published in the journal Nature found that people who had received an mRNA COVID-19 vaccine were at an increased risk of developing retinal vascular occlusion (RVO), a type of stroke that affects the blood vessels in the retina.
The study, which was conducted by researchers at the University of California, San Francisco, analyzed data from over 100 million people who had received a COVID-19 vaccine. The researchers found that people who had received the Pfizer-BioNTech vaccine were at a 2.19-fold increased risk of developing RVO, while people who had received the Moderna vaccine were at a 1.52-fold increased risk.
The risk of retinal vascular occlusion significantly increased in individuals receiving the first and second doses of BNT162b2 (Pfizer) and mRNA1273 (Moderna) within 2 years. (Table 3 below)
Folks, there is no good reason to continue getting vaccinated against COVID-19. (I realize that many of you who are reading this article have never been vaccinated or have stopped getting vaccinated but there are clearly people still getting vaccinated and this is for them).
Study after study has shown that the risks of vaccination outweigh the benefits. (If you even believe that vaccination actually prevents severe disease, which is debatable.) Also, please be aware that you may be given a new combination shot if you choose to get your flu shot next year.
The public is getting so misled by big pharma. If you still don’t understand that read the full transcript from the Pfizer earning call — they are only interested in your money.
I’m so glad you're here! I hope you're enjoying this Substack. If you are, please consider sharing the link with your friends and colleagues. And if you're able, please consider becoming a paid subscriber. For just $5.00 per month, you can help continue my research and reporting. Your support is greatly appreciated.
Healthy 37 year old died on American Airlines Flight from an aortic dissection.